GoodRx Inc.

NASDAQ: GDRX · Real-Time Price · USD
3.75
0.21 (5.93%)
At close: Aug 15, 2025, 1:22 PM

GoodRx Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
16.39M -8.87M -32.83M -25.25M
Depreciation & Amortization
69.54M 111.77M 54.18M 34.54M
Stock-Based Compensation
99.03M 104.82M 120.23M 160.46M
Other Working Capital
n/a -12.93M -20.79M 27.95M
Other Non-Cash Items
n/a 18.07M 25.98M 7.98M
Deferred Income Tax
n/a -65.56M -497K 12.85M
Change in Working Capital
2.09M -21.94M -20.29M -11.8M
Operating Cash Flow
183.89M 138.29M 146.78M 178.78M
Capital Expenditures
-70.35M -55.77M -55.21M -34.46M
Cash Acquisitions
n/a n/a -155.28M -144.28M
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-69.11M -54.72M -34.67M -29.89M
Investing Cash Flow
-70.35M -55.77M -210.5M -178.73M
Debt Repayment
-167M -5.27M -7.03M -7.03M
Common Stock Repurchased
-158.84M -103.97M -101.72M -57.69M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-11.64M -58.15M -11.48M -23.5M
Financial Cash Flow
-337.5M -167.4M -120.23M -30.53M
Net Cash Flow
-223.95M -84.87M -183.94M -30.48M
Free Cash Flow
113.55M 82.53M 91.57M 144.32M